Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB
Mandate

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB

March 02, 2016

Vinge advises Air Liquide Advanced Business S.A. and its wholly owned subsidiary FordonsGas Sverige AB in connection with the acquistion of Lidköping Biogas AB. Lidköping Biogas produces liquid biogas for inter alia trucks and has an annual capacity of 60 GWh.

FordonsGas operates and builds gas tank stations in Sweden, and currenly operates more than 40 gas tank stations, predominantly in the western part of Sweden. Through the acquisition of Lidköping Biogas, FordonsGas Sverige will get an even better control over the production chain and can further develop sustainable mobility.

The Vinge team advising Air Liquide Advanced Business S.A./FordonsGas Sverige AB consists of Jesper Ottergren together with Anna Edström and, inter alia, Christoffer Thalin, Mathias Lindquist, Emma Hakesjö and Cecilia Cronquist.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025